Paradigm Change Coming in Secondary Stroke Prevention Neurologist Christoph Diener discusses the OCEANIC-STROKE trial comparing the novel factor XIa inhibitor, asundexian with placebo for secondary ...
Indu Subramanian, MD Clinical Professor, Department of Neurology, University of California Los Angeles; PADRECC Director, West Los Angeles Veterans Association, Los Angeles, California Simple Steps to ...
New neurology approvals: FDA cleared an Alzheimer’s agitation drug, a wearable tremor device, and advanced a rare disease gene therapy. Federal deprescribing push: HHS unveiled a plan to reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results